
Founded in 2001, Altaris Capital Partners is an investment firm that operates exclusively within the healthcare sector. The firm identifies and builds market-leading companies poised to make significant strides in efficiency and innovation throughout the healthcare system. With a mission centered on improving patient access and outcomes, Altaris strategically focuses on businesses that align with the evolving demands of healthcare services. At the core of Altaris' investment thesis lies a comprehensive understanding of the healthcare landscape and its intricate dynamics. The firm employs a diverse range of strategies including Expansion investments, Management Buyouts (MBOs), Leveraged Buyouts (LBOs), Recapitalizations, as well as Seed funding and Series A to Series B financing. This flexibility allows for tailored solutions depending on each portfolio company's unique needs while ensuring alignment with growth-oriented targets. The evaluation process at Altaris hinges on rigorous analytical frameworks that assess both opportunity potential and associated risks. This disciplined approach encompasses detailed market analyses, operational assessments, and financial reviews to inform decision-making. The firm prioritizes sectors where it can leverage existing knowledge—such as health technology, pharmaceuticals, medical devices, and service providers—to navigate complexities effectively while identifying high-value opportunities for investment. With approximately $2.6 billion in assets under management, Altaris possesses significant financial resources which it deploys judiciously across its chosen verticals. Its typical equity investments range from $100,000 to $5 million; however, strategic considerations often dictate larger commitments based on individual company prospects or collaboration requirements within broader corporate partnerships. This capital deployment philosophy reflects not just an intention to provide financial backing but also a commitment to fostering sustainable growth trajectories among portfolio companies. What sets Altaris apart from other firms in the private equity space is its unwavering dedication to responsible investing practices combined with strong operational involvement post-investment. The firm's investment strategy extends beyond mere capital infusion; it emphasizes creating value through active management support aimed at enhancing operational efficiencies and achieving scalable outcomes for patients and healthcare providers alike. This holistic viewpoint fosters enduring relationships with management teams who are aligned in their vision for transformation within their respective segments of the industry. Having successfully completed over 50 platform investments—including more than 25 carve-outs—Altaris demonstrates a robust capability in nurturing strong operational models within the healthcare ecosystem. These endeavors highlight not only impressive returns but also tangible improvements in quality care delivery across various markets. Located at 10 East 53rd Street in New York City—the heart of one of the world’s most vibrant centers for healthcare innovation—Altaris benefits from close proximity to key industry players, emerging trends, and networking opportunities critical for informed decision-making processes. The dynamic backdrop bolsters its ability to stay ahead by continuously adapting its strategies based on real-time insights into market shifts affecting stakeholders across all levels of health systems. In summary, Altaris Capital Partners operates at the intersection of finance and transformative healthcare solutions. Through thoughtful investments backed by solid analysis paired with ethical business practices focused on meaningful impact—as opposed solely capturing profit—the firm seeks to redefine what success looks like within this vital industry space while championing excellence through accountability each step along its journey toward shaping future possibilities in patient care delivery.